ARC Regulatory set to attend the 9th Clinical Biomarkers & World CDx Boston 2018 summit on October 4-5, 2018.
The 9th Clinical Biomarkers & World CDx Boston 2018 summit is once again the home for the biomarker, translational and diagnostic community to accelerate the translation from exploratory biomarker into clinically validated signature and ultimately a proven, predictive IVD.
As the place to be for the precision medicine field, Clinical Biomarkers & World CDx Boston covers end-to-end the development, clinical implementation and commercialisation of a biomarker strategy to increase market penetration and market share for a targeted therapeutic. Ultimately, the meeting is here to streamline the path from R&D to providing patients with the right treatment decision and most effective therapies at the right time.
Share this post